June 16, 2021
June 16, 2021 – The U.S. FDA has approved a new indication for AyvakitTM (avapritinib), manufactured by Blueprint Medicines. The drug is now indicated to treat adults who have
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
Pharmacy Benefits Management
June 15, 2021
June 15, 2021 – The U.S. FDA has approved Rezipres® (ephedrine hydrochloride injection), manufactured by Eton Pharmaceuticals, to treat clinically important hypotension occurring
June 15, 2021
June 15, 2021 – The U.S. FDA has approved a new indication for Pradaxa® (dabigatran etexilate), manufactured by Boehringer Ingelheim, to treat children at least
June 15, 2021
June 15, 2021 – The U.S. FDA has approved StrataGraft® (allogeneic cultured keratinocytes and dermal
fibroblasts in murine collagen-dsat), manufactured by Mallinckrodt, to treat adults
June 14, 2021
June 14, 2021 – The U.S. FDA has approved expanded indications for Epclusa® (sofosbuvir/velpatasvir –
Gilead) and Mavyret® (glecaprevir/pibrentasvir
June 11, 2021
June 11, 2021 – Viona Pharmaceuticals, Inc., has recalled two lots of Metformin Hydrochloride Extended-
Release Tablets, USP 750mg due to the detection of N-nitrosodimethylamine
June 10, 2021
June 10, 2021 – The U.S. FDA has approved an expanded indication for Trikafta® (elexacaftor/tezacaftor/
ivacaftor), manufactured by Vertex Pharmaceuticals. The drug is now indicated
June 10, 2021
June 10, 2021 – The U.S. FDA has authorized an extension to the shelf life for Johnson & Johnson’s (J&J)
COVID-19 vaccine, manufactured by J&J subsidiary Janssen